Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Eslicarbazepine Acetate in Elderly Patients with Partial Seizures
NCT01422720Phase 3Completed
- Sponsor
- BIAL
- Start
- Apr 2010
- Primary completion
- Sep 2013
- Modality
- Small Molecules
- Countries
- 10
01
Overview
A Phase 3 trial of eslicarbazepine acetate in epilepsy, sponsored by BIAL. Started Apr 2010; status: completed.
02
Drugs
eslicarbazepine acetate
03
Conditions
epilepsy
Beyond the preview
Go deeper on NCT01422720.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01422720.